Future strategies of reverse remodeling: summation.
Poole-Wilson
Philip A
PA
Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College of Science, Technology, and Medicine, London, England.
Katz
Arnold M
AM
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D006332:Cardiomegaly / Q000517:prevention & control*; D006333:Heart Failure / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D015398:Signal Transduction; D020257:Ventricular Remodeling
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors